Genetic screening of patients with familial hypercholesterolaemia (FH): a New Zealand perspective
- 31 December 2004
- journal article
- other
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 5 (5) , 13-15
- https://doi.org/10.1016/j.atherosclerosissup.2004.09.001
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohortHuman Mutation, 2002
- A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United KingdomEuropean Journal of Human Genetics, 2001
- Mutation analysis in a small cohort of New Zealand patients originating from the United Kingdom demonstrates genetic heterogeneity in familial hypercholesterolemiaMolecular and Cellular Probes, 2000
- I705 variant in the low density lipoprotein receptor gene has no effect on plasma cholesterol levelsJournal of Medical Genetics, 2000
- Screening for mutations in exon 4 of the LDL receptor gene: identification of a new deletion mutation.Journal of Medical Genetics, 1995
- Molecular genetics of the LDL receptor gene in familial hypercholesterolemiaHuman Mutation, 1992